Breaking News

Eurofins Acquires Merck KGaA’s DDS Business

Expands presence in discovery pharmacology and bioanalysis

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Eurofins Scientific has signed an agreement to acquire the assets of the Discovery and Development Solutions (DDS) business of Merck Millipore (EMD Millipore), the Life Science division of Merck KGaA. DDS provides bioanalytical testing and early stage discovery services and products to the biopharmaceutical industry and generates revenues of approximately $35 million with 175 employees from three sites in St. Charles, MO, Dundee, Scotland and Oxford, England.   DDS also provides expertise in bio...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters